Eli Lilly Current Ratio 2006-2018 | LLY

Current and historical current ratio for Eli Lilly (LLY) from 2006 to 2018. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Eli Lilly current ratio for the three months ending December 31, 2018 was 1.73.
Eli Lilly Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2018-12-31 $20.55B $11.89B 1.73
2018-09-30 $20.69B $10.83B 1.91
2018-06-30 $18.33B $13.06B 1.40
2018-03-31 $16.26B $11.55B 1.41
2017-12-31 $19.20B $14.54B 1.32
2017-09-30 $17.43B $12.67B 1.38
2017-06-30 $15.75B $11.30B 1.39
2017-03-31 $12.98B $10.45B 1.24
2016-12-31 $15.10B $10.99B 1.38
2016-09-30 $13.39B $8.27B 1.62
2016-06-30 $12.98B $8.40B 1.55
2016-03-31 $11.72B $7.34B 1.60
2015-12-31 $12.57B $8.23B 1.53
2015-09-30 $12.57B $8.30B 1.51
2015-06-30 $12.35B $8.23B 1.50
2015-03-31 $11.74B $8.34B 1.41
2014-12-31 $11.93B $9.74B 1.23
2014-09-30 $12.11B $7.58B 1.60
2014-06-30 $13.16B $7.42B 1.77
2014-03-31 $13.04B $6.63B 1.97
2013-12-31 $13.11B $8.92B 1.47
2013-09-30 $13.20B $8.08B 1.64
2013-06-30 $12.64B $8.41B 1.50
2013-03-31 $12.33B $7.59B 1.62
2012-12-31 $13.04B $8.39B 1.55
2012-09-30 $14.04B $6.96B 2.02
2012-06-30 $12.31B $6.61B 1.86
2012-03-31 $12.60B $6.55B 1.92
2011-12-31 $14.25B $8.93B 1.60
2011-09-30 $14.57B $8.22B 1.77
2011-06-30 $14.95B $8.62B 1.73
2011-03-31 $15.35B $7.65B 2.01
2010-12-31 $14.84B $6.93B 2.14
2010-09-30 $14.18B $6.10B 2.33
2010-06-30 $12.47B $6.33B 1.97
2010-03-31 $12.25B $5.66B 2.17
2009-12-31 $12.49B $6.57B 1.90
2009-09-30 $11.81B $6.07B 1.95
2009-06-30 $10.94B $6.99B 1.57
2009-03-31 $10.26B $7.36B 1.40
2008-12-31 $12.45B $13.11B 0.95
2008-09-30 $12.95B $6.51B 1.99
2008-06-30 $12.68B $5.26B 2.41
2008-03-31 $12.49B $4.16B 3.00
2007-12-31 $12.32B $5.44B 2.27
2007-09-30 $10.45B $4.07B 2.57
2007-06-30 $9.56B $4.55B 2.10
2007-03-31 $9.25B $4.15B 2.23
2006-12-31 $9.69B $5.09B 1.91
2006-09-30 $9.77B $3.88B 2.52
2006-06-30 $10.59B $4.65B 2.28
2006-03-31 $10.36B $4.53B 2.29
2005-12-31 $10.80B $5.72B 1.89
2005-09-30 $11.95B $5.09B 2.35
2005-06-30 $10.95B $6.46B 1.70
2005-03-31 $11.26B $5.38B 2.09
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $132.855B $24.556B
Eli Lilly and Company is a global healthcare leader that unites caring with discovery to make life better for people around the world. They were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and they remain true to that mission in all their work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $370.509B 16.88
Pfizer (PFE) United States $252.104B 14.12
Merck (MRK) United States $223.649B 19.11
Novartis AG (NVS) Switzerland $216.355B 18.40
Novo Nordisk (NVO) Denmark $127.479B 20.62
AbbVie (ABBV) United States $119.836B 10.27
Sanofi (SNY) France $113.942B 14.06
AstraZeneca (AZN) United Kingdom $108.788B 12.41
GlaxoSmithKline (GSK) United Kingdom $102.300B 13.43
Bristol-Myers Squibb (BMY) United States $79.871B 12.29